These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13154419)

  • 1. [Binding and elimination of cardiac glycosides in the liver and kidneys of guinea pig].
    GIERTZ H; HAHN F; SCHUNK R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 221(1):34-49. PubMed ID: 13154419
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the distribution and metabolism of 3H-peruvoside in the guinea pig].
    Schaum E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):194. PubMed ID: 4239224
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic degradation of 3H-labelled cardiac glycosides by the isolated perfused guinea pig liver].
    Kolenda KD; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):374-5. PubMed ID: 4253809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum level and excretion of H3 labeled cardiac glycosides under normal and pathological conditions].
    Lahrtz H; van Zwieten PA
    Radiobiol Radiother (Berl); 1969; 10(6):841. PubMed ID: 5379979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism of helveticoside and helveticosol derivatives].
    Kaiser F; Schaumann W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):87-96. PubMed ID: 4237044
    [No Abstract]   [Full Text] [Related]  

  • 6. The absorption, distribution and excretion of K-strophanthoside-3H in guinea pigs after parenteral administration.
    Marzo A; Ghirardi P; Marchetti G
    J Pharmacol Exp Ther; 1974 Apr; 189(1):185-93. PubMed ID: 4823291
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the rate of elimination of digoxigenin in the guinea pig on the determination of its lethal dose.
    RAND M; STAFFORD A
    Nature; 1959 Mar; 183(4662):688-9. PubMed ID: 13632839
    [No Abstract]   [Full Text] [Related]  

  • 8. Accumulation of cardiac glycosides.
    Kuschinsky K
    Ger Med Mon; 1969 Apr; 14(4):198-202. PubMed ID: 4896950
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the distribution and metabolism of H3-peruvoside in guinea pigs].
    Lüllmann H; Schaum E
    Arzneimittelforschung; 1968 Dec; 18(12):1605-9. PubMed ID: 5756261
    [No Abstract]   [Full Text] [Related]  

  • 10. [The enzymatic decomposition of D-digitoxose, D-cymarose and L-thevetose from cardiac glycosides by liver sections].
    LAUTERBACH F; REPKE K; NITZ D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 239():196-218. PubMed ID: 14414609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiac glycosides--clinically relevant interactions].
    Kuhlmann J
    Med Monatsschr Pharm; 1982 Mar; 5(3):65-79. PubMed ID: 7040928
    [No Abstract]   [Full Text] [Related]  

  • 12. [Absorption, distribution and biliary excretion of some 3H-labelled derivatives of helveticosol].
    Zielske F; Voigtländer W; Schaumann W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):49-66. PubMed ID: 4254219
    [No Abstract]   [Full Text] [Related]  

  • 13. [Affinity of various structured cardiac glycosides, DPH and Ro 2-2985 to the receptor of cardiac glycosides].
    Erdmann E; Schoner W
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():309-14. PubMed ID: 4281217
    [No Abstract]   [Full Text] [Related]  

  • 14. [The binding capacity of serum proteins for cardiac glycosides (especially for pengitoxin)].
    Emmrich R; Wagner J; Axthelm EH
    Munch Med Wochenschr; 1969 Feb; 111(8):401-4. PubMed ID: 5818954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative aspects of the specific binding of cardiac glycosides to membrane-bound receptors].
    Erdmann E
    Fortschr Med; 1978 Sep; 96(35):1758. PubMed ID: 738687
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological transformation of cardiac glycosides].
    Gvozdiak PI; Kolesnikov DG
    Izv Akad Nauk SSSR Biol; 1966; 5():667-85. PubMed ID: 6004710
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cleavage of cardiac glycosides in the animal body].
    ENGLER R; HOLTZ P; RAUDONAT HW
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 233(5):393-408. PubMed ID: 13552769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of cardiac glycosides in animals].
    DE GRAEVE P; BASCHUNG M
    Ann Pharm Fr; 1955 Nov; 13(11):705-12. PubMed ID: 13302948
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enzymatic hydrolysis of cardiac glycosides by elaterase].
    ENSLIN PR; REHM S
    Hoppe Seylers Z Physiol Chem; 1956 Mar; 303(3-6):97-101. PubMed ID: 13331463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.